Select Publications
Journal articles
2002, 'Acute Q fever and brachial neuritis: Case report and literature review', Infection, 30, pp. 400 - 402
,2002, 'Immunity against hepatitis C virus infection', Lancet, 360, pp. 1020 - 1020
,2001, 'Rapid disease progression and the rate of spread of the HIV epidemic', AIDS, 15, pp. 2055 - 2057, http://dx.doi.org/10.1097/00002030-200110190-00024
,2001, 'Acute hepatitis C virus infection in an Australian prison inmate: tattooing as a possible transmission route', Medical Journal of Australia, 174, pp. 183 - 184
,2001, 'Rapid disease and the rate of spread of the HIV epidemic', AIDS, 15, pp. 2055 - 2059
,2001, 'Tattoo-related brachial plexopathies with adjacent muscle atrophy', Annals of Internal Medicine, 134, pp. 715 - 715
,2000, 'Interferon inducible protein 10 is expressed by hepatocytes in chronic hepatitis C virus infection and correlates with lobular inflammation.', HEPATOLOGY, 32, pp. 374A - 374A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000089622400847&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2000, 'Gynecomastia and HAART.', The AIDS reader, 10, pp. 314
,2000, 'Gynecomastia and HAART (multiple letters)', AIDS Reader, 10, pp. 314
,2000, 'Gynaecomastia and HAART', AIDS Reader, 10, pp. 314 - 314
,1999, 'Gynaecomastia associated with combination antriretroviral therapy including protease inhibitors for human immunodeficiecny virus infection', International Journal of STD and AIDS, 10, pp. 275 - 276
,1999, 'Unusual cluster of mild invasive serogroup C meningococcal infect-ion in a university college', Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, pp. 261 - 264
,Conference Papers
2016, 'Vaccination induced ICOS+ circulating memory TFH cells share similar characteristics to TFH cells but are dysfunctional and Th2 skewed in chronic HIV-1 infection', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 992 - 993, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610402390&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Using theory to increase understanding of the non-initiation of subsidized HIV-treatment: the interplay of motivational and volitional processes', in INTERNATIONAL JOURNAL OF PSYCHOLOGY, ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, pp. 662 - 662, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413720405028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'CLINICAL CHARACTERISTICS AND OUTCOME OF INFECTIVE ENDOCARDITIS INVOLVING IMPLANTABLE CARDIAC DEVICES', in INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, ELSEVIER SCIENCE BV, CROATIA, Dubrovnik, pp. S3 - S3, presented at 12th International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections, CROATIA, Dubrovnik, 19 May 2013 - 21 May 2013, http://dx.doi.org/10.1016/S0924-8579(13)70010-4
,2005, 'Prevalence of risk factors for HCV transmission in HIV infected and HIV/HCV co-infected patients', in HEPATOLOGY, JOHN WILEY & SONS INC, CA, San Francisco, pp. 423A - 423A, presented at 56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, CA, San Francisco, 11 November 2005 - 15 November 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000232480301117&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2002, 'Cellular immunity in people resistant to HCV infection.', in HEPATOLOGY, W B SAUNDERS CO, MASSACHUSETTS, BOSTON, pp. 263A - 263A, presented at 53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), MASSACHUSETTS, BOSTON, 01 November 2002 - 05 November 2002, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000178301700383&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1998, 'Antiviral therapy in a large Australian HIV ambulatory care clinic', in AIDS, LIPPINCOTT WILLIAMS & WILKINS, pp. S49 - S49, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000077311300189&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Conference Presentations
2015, 'Taking Treatment as Prevention into practice: growing support among antiretroviral treatment prescribers in Australia', presented at AIDS Impact, Amsterdam, 28 July 2015 - 31 July 2015
,Conference Abstracts
2021, 'STANDARDISED TESTING AND COMMUNICATION INCREASE BETA-LACTAM ALLERGY DELABELLING EFFECTIVENESS: RESULTS OF 'DE-LABELLING PATIENTS WITH ANTIBIOTIC ALLERGY IN SYDNEY ADULT AND PAEDIATRIC HOSPITALS'', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 51, pp. 13 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000713717300029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'De-labelling patients with antibiotic allergy in Sydney adult and paediatric hospitals-towards standardisation and improved patient outcomes', in ALLERGY, WILEY, ENGLAND, London, Vol. 75, pp. 216 - 216, presented at European-Academy-of-Allergology-and-Clinical-Immunology Digital Congress (EAACI), ENGLAND, London, 06 June 2020 - 08 June 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000566847300395&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'DE-LABELLING PATIENTS WITH ANTIBIOTIC ALLERGY IN SYDNEY ADULT AND PAEDIATRIC HOSPITALS- TOWARDS STANDARDISATION AND IMPROVED PATIENT OUTCOMES', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 49, pp. 15 - 15, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488891400038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia', in JOURNAL OF HEPATOLOGY, ELSEVIER, AUSTRIA, Vienna, Vol. 70, pp. E734 - E734, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), AUSTRIA, Vienna, 10 April 2019 - 14 April 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463481703225&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'High efficacy of HCV therapy following universal DAA access in Australia: the REACH-C cohort', in JOURNAL OF VIRAL HEPATITIS, WILEY, CANADA, Toronto, Vol. 25, pp. 54 - 54, presented at 16th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), CANADA, Toronto, 14 June 2018 - 17 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435101000087&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Reports
2022, PrEP in Practice Research Summary Report: A Qualitative Study Investigating the Perspectives of Clinicians who Prescribe PrEP in Australia, http://dx.doi.org/10.26190/dh7v-gx71
,Theses / Dissertations
2008, Primary hepatitis C virus infection in prisons
,Preprints
2023, A unique cytotoxic CD4+T cells signature defines critical COVID-19, http://dx.doi.org/10.1101/2023.02.17.23286059
,2022, Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients, http://dx.doi.org/10.1101/2022.10.19.512954
,2020, Differences in Antibiotic and Antiviral Use in People With Confirmed Influenza: a Retrospective Comparison of Rapid Influenza PCR and Multiplex Respiratory Virus PCR Tests., http://dx.doi.org/10.21203/rs.3.rs-109807/v1
,2020, Long-term persistence of neutralizing memory B cells in SARS-CoV-2, http://dx.doi.org/10.21203/rs.3.rs-92527/v1
,Moving Towards HCV Elimination Among People Living with HIV in Australia: Analysis of the CEASE Prospective Cohort Study, http://dx.doi.org/10.2139/ssrn.3269607
,